| Name | Title | Contact Details |
|---|
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
Axess Ultrasound is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RAAS BLOOD PRODUCTS CO., LTD. is a Agoura Hills, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Palo Alto Research Center is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Acubalance Wellness Centre is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.